Clinical utility and patient considerations in the use of the sitagliptin-metformin combination in Chinese patients
Qiang Du, Yan-Jun Wang, Sheng Yang, Ping HanDepartment of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People’s Republic of ChinaAbstract: The prevalence of diabetes mellitus (DM) continues to increase each year. However, the efficacy of glucose-lower...
Main Authors: | Du Q, Wang YJ, Yang S, Han P |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-02-01
|
Series: | Patient Preference and Adherence |
Online Access: | http://www.dovepress.com/clinical-utility-and-patient-considerations-in-the-use-of-the-sitaglip-peer-reviewed-article-PPA |
Similar Items
-
Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes
by: Green J, et al.
Published: (2010-10-01) -
Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes
by: Karen Barnard, et al.
Published: (2010-10-01) -
Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
by: Alexander Sergeevich Ametov, et al.
Published: (2010-09-01) -
Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients
by: Degli Esposti L, et al.
Published: (2014-10-01) -
New combination treatments in the management of diabetes: focus on sitagliptin – metformin
by: Jennifer Green, et al.
Published: (2008-08-01)